Additional information
| Active substance | Ampicillin |
|---|---|
| Water Retention | No significant effect |
| Hepatotoxicity | Rare, but hepatitis and cholestatic jaundice have been reported |
| Lab Test | No specific lab test required for monitoring ampicillin therapy |
| Strength | 250mg |
| Also known as | Penbritin, Alpen |
| Blood pressure | No direct effect |
| Trade name | Principen, Omnipen, others |
| Storage conditions | Store at room temperature away from moisture and heat |
| Chemical name | (2S,5R,6R)-6-[(R)-2-Amino-2-phenylacetamido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid |
| Formula | C16H19N3O4S |
| Substance class | Antibiotic, specifically a beta-lactam |
| Main action | Bactericidal (kills bacteria by inhibiting cell wall synthesis) |
| Half-life | Approximately 1 hour |
| Dosage (medical) | Typically 250 mg to 500 mg every 6 hours orally, or 500 mg to 2 grams every 6 to 8 hours intravenously, depending on the type and severity of infection |
| Dosage (sports) | Not applicable |
| Effects | Effective against Gram-positive and some Gram-negative bacteria |
| Side effects | Rash, diarrhea, nausea, allergic reactions (including anaphylaxis), and potential superinfection |
| Use in sports | None |
| Manufacturer | Omega Pharma |
| Packing | 10 caps/blister |
Fostimon (Merional) 75 (HMG) IBSA
Seretide Disckus (Advair) 250 mcg Glaxosmithkline
Prograf 5mg Astellas Pharma
DELETE - Micardis 80 mg Boehringer Ingelheim
FACTIVE 320 mg Abdi Ibragim
Zyban Glaxosmithkline
FUCIDIN 500 mg Abdi Ibragim
Fostimon (Merional) 150 IU HMG IBSA
Norvacs 10 mg Pfizer
Rovamycine 3.000.000 iu Eczacibasi
BIOSYNERGY RECOVERY3 PEPTIDE BLEND LIFETECH LABS 

Reviews
There are no reviews yet.